Continued Correspondence with Novalpina on NSO Acquisition
Without Novalpina Capital—or the parties that you hired to conduct due diligence—concluding that Citizen Lab reporting is flawed and providing a substantiated basis to prove such a finding, it remains the case that you are purchasing a company implicated in serious human rights abuses and have decided to simply ignore this fact. It also remains the case that, without meaningful engagement with our research, your due diligence process will appear to many as nothing more than a superficial effort to check boxes and appease stakeholders concerned by NSO Group.